Skip to content
Companies

Magnus Medical

Accelerated magnetic brain stimulation for depression

Raised to date

$89.3M

of $136M offered across 3 Form D filings

Still open
$46.7M
Investors
10
Last filed
May 26, 2026

About

Magnus Medical, Inc. is a pioneering medical device company that specializes in developing advanced neuromodulation technology aimed at addressing major depressive disorder (MDD). With a focus on innovative treatments for those suffering from treatment-resistant depression, Magnus Medical is at the forefront of mental health solutions, utilizing cutting-edge neuroscience to improve patient outcomes.

What sets Magnus Medical apart is its SAINT neuromodulation system, which combines personalized brain mapping with high-dose stimulation to provide rapid and effective treatment options for patients who have not responded to traditional therapies.

Funding

$77M round, first sold May 2025$49M sold$28M still openFeb 20252026
Now
  • EquityFiled May 26, 2026Form D/A
    $49M/ $77M
  • EquityFiled May 12, 2025Form D
    $23.7M/ $77M
  • EquityFiled Mar 14, 2025Form D
    $40.3M/ $59M

Product

SAINT (Stanford Accelerated Intelligent Neuromodulation Therapy)

Medical Device

The SAINT system is an advanced neuromodulation device that employs transcranial magnetic stimulation (TMS) to deliver individualized and accelerated treatment for major depressive disorder. This innovative approach focuses on identifying precise brain targets, ensuring that treatment is tailored to the unique physiology of each patient.

  • Utilizes structural and functional MRI scans for personalized brain target identification
  • Delivers high-dose intermittent theta burst stimulation (iTBS)
  • Offers a rapid and efficient 5-day treatment protocol

Built for

Adult patients suffering from treatment-resistant major depressive disorder

People on file